In tumoral cells, ANG-2 has been shown to bind and signal through other types of receptors, such as integrins, resulting in glioma cell invasion [66,67] and increased breast cancer cell survival and invasion [68]. This evidence concerns the gene ANGPT2 and central nervous system cancer.